Clinical Trial

JOURNEY II XR Safety and Effectiveness PMCF

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
This study was designed to demonstrate the safety and performance of the JOURNEY II XR total knee system by evaluating implant survival rates at 10 years using Kaplan-Meier analysis. All participants will be implanted with the JOURNEY II XR total knee system.
Protocol Amendment History 13 amendments
This ClinicalTrials.gov record has been amended 13 times since 2017-04-27; most recent amendment 2024-08-09.
Status change: Recruiting → Active, Not Recruiting 2020-01-15
Status change: Not Yet Recruiting → Recruiting 2017-09-06
Trial Details
NCT Number NCT03136887
Lead Sponsor Smith & Nephew, Inc.
Conditions Rheumatoid Vasculitis With Rheumatoid Arthritis of Knee, Unilateral Post-Traumatic Osteoarthritis of Knee, Knee Osteoarthritis, Degenerative Arthritis Peripheral Joint, Failed Osteotomies, Failed Unicompartmental Replacement
Enrollment 176 participants
Start Date 2017-07-28
Primary Completion 2029-04 (estimated)
Study Completion 2029-04 (estimated)
Updated on ClinicalTrials.gov 2024-08-12